Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
Baylor College of Medicine, Houston, Texas, United States
Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
University of Maryland, Baltimore, Maryland, United States
Queen Jadwiga Hospital, Rzeszów, Poland
University Hospitals, Cleveland, Ohio, United States
Sahlgrenska UH, Mölndal, Västra Götaland, Sweden
Oslo University Hospital, Oslo, Norway
Lotus Clinical Research, LLC, Pasadena, California, United States
Epic Medical Research, Murray, Utah, United States
Institut réginal du Cancer de Montpellier, Montpellier, France
Yeungnam University Hospital, Daegu, Nam-gu, Daegu, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.